Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Alza Corp | 928 |
| 2 | Takeda Pharmaceutical Co Ltd | 633 |
| 3 | Boehringer Ingelheim Animal Health USA Inc | 395 |
| 4 | Emisphere Technologies Inc | 280 |
| 5 | Ferring BV | 279 |
| 6 | University of California San Diego UCSD | 267 |
| 7 | Pharmacia and Upjohn Co | 261 |
| 8 | Massachusetts Institute of Technology | 252 |
| 9 | Leland Stanford Junior University | 245 |
| 10 | Novo Nordisk AS | 243 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 27,325 |
| 2 | A61P | Therapeutic activity (drug indications) | 22,080 |
| 3 | C07K | Peptides | 9,618 |
| 4 | C12N | Microorganisms, enzymes | 7,136 |
| 5 | C07D | Heterocyclic compounds | 5,897 |
| 6 | G01N | Investigating / analysing materials | 4,555 |
| 7 | A61M | Devices for introducing media into the body | 3,857 |
| 8 | Y02A | Climate change adaptation | 2,881 |
| 9 | C07C | Acyclic and carbocyclic compounds | 2,235 |
| 10 | A61B | 1,837 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Tocolytic oxytocin receptor antagonists | 1995 | Merck and Co Inc | 134 |
| Closed-loop system for infusing oxytocin | 1996 | PAGER; DAVID | 131 |
| Tocolytic oxytocin receptor antagonists | 1998 | Merck and Co Inc | 112 |
| 1,6 - SUBSTITUTED (3R,6R) -3- (2,3-DIHYDRO-1H-INDEN-2-YL)-2,5-PIPERAZINEDIONE DERIVATIVES AS OXYTOCIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PRE-TERM LABOUR, DYSMENORRHEA AND ENDOMETRIOSIS | 2006 | Glaxo Group Ltd | 81 |
| Carbostyril oxytocin receptor antagonists | 1994 | Merck and Co Inc | 79 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Neuroendocrine regulation and behavior | 254 |
| 2 | Maternal and Perinatal Health Interventions | 55 |
| 3 | Reproductive Physiology in Livestock | 29 |
| 4 | Maternal and fetal healthcare | 26 |
| 5 | Preterm Birth and Chorioamnionitis | 11 |
| 6 | Cardiovascular Issues in Pregnancy | 7 |
| 7 | Electrolyte and hormonal disorders | 7 |
| 8 | Pregnancy and preeclampsia studies | 6 |
| 9 | Pregnancy-related medical research | 6 |
| 10 | Birth, Development, and Health | 5 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Gareth Leng | University of Edinburgh | 100 |
| 2 | Inga D. Neumann | University of Regensburg | 95 |
| 3 | C. Sue Carter | Indiana University Bloomington | 88 |
| 4 | Kerstin Uvnäs‐Moberg | Karolinska Institutet | 70 |
| 5 | Larry J. Young | Emory University | 70 |
| 6 | Vincent du Vigneaud | Cornell University | 59 |
| 7 | Roderich Walter | City University of New York | 58 |
| 8 | Janet A. Amico | University of Pittsburgh | 57 |
| 9 | Anna‐Riitta Fuchs | Cornell University | 53 |
| 10 | Keith M. Kendrick | University of Electronic Science and Technology of China | 52 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Oxytocin increases trust in humans | 2005 | 3686 | Attachment and Relationship Dynamics |
| The Oxytocin Receptor System: Structure, Function, and Regulation | 2001 | 3087 | Hypothalamic control of reproductive hormones |
| Rapid analysis of amino acids using pre-column derivatization | 1984 | 2520 | Analytical Chemistry and Chromatography |
| Mechanisms of action of transmitters and other substances on smooth muscle. | 1979 | 2194 | Pharmacological Effects of Natural Compounds |
| Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress | 2003 | 2087 | Child and Adolescent Psychosocial and Emotional Development |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of oxytocin?
Which organizations hold the most patents related to oxytocin?
What are the major research topics covered in oxytocin literature?
Who are the most prolific authors publishing on oxytocin?
What are the most frequently cited highly-impactful papers on oxytocin?